跳至主要内容
临床试验/NCT04780412
NCT04780412Unknown3 期

Efficacy of Misoprostol in Prevention of Neonatal Respiratory Morbidity in Parturient at Early Term Elective Caesarian Section

Ain Shams University1 个研究点 分布在 1 个国家目标入组 210 人开始时间: 2020年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
入组人数
210
试验地点
1
主要终点
incidence of neonatal respiratory morbidity (NRM)

研究概览

简要总结

Neonatal respiratory morbidities represent a common group of post natal complications including respiratory distress syndrome, transient tachypnea of newborn, and persistent pulmonary hypertension of newborn.

It is thought that preoperative vaginal misoprostol administration may decrease the incidence of neonatal respiratory morbidity especially transient tachypnea of newborn. And therefore, it may decrease the incidence of admission to neonatal intensive care units for respiratory causes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age: 18 years or more.
  • Early term singleton pregnancy.
  • Elective caesarian section at (37 - 38+6) weeks of gestation.
  • Any indication for lower uterine segment caesarian section other than labor (as malpresentations, severe preeclampsia, placenta previa with no previous bleeding attacks, Diabetes Mellitus, macrosomic fetus, non reassuring cardiotocogram (CTG), and fetal growth restriction).
  • Informed written consent signed by the participating pregnant woman.

排除标准

  • Women having any contraindication to Prostaglandin E1 as hypersensitivity, respiratory disease (especially bronchial asthma), or glaucoma.
  • Any mental problems that block understanding of the nature and all the possible consequences of the procedure and the study.
  • Pregnancies of known fetal diseases or chromosomal abnormalities.
  • Non-singleton pregnancies.
  • Emergency caesarian section as in ruptured membrane and women in labor pain.

研究组 & 干预措施

Misoprostol Group

Active Comparator

干预措施: Misoprostol (Drug)

Placebo Group

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

incidence of neonatal respiratory morbidity (NRM)

时间窗: up to 24 hours after birth

The incidence of neonatal respiratory morbidity, especially transient tachypnea of newborn, in early term neonates born to elective caesarian section.

次要结局

  • Neonatal intensive care unit (NICU) admission(up to 24 hours after birth)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Samar Ali

Principal Investigator

Ain Shams University

研究点 (1)

Loading locations...

相似试验